Chemexpress

We will deepen research and development and innovation, accumulate remarkable achievements, remain true to our original aspiration, and forge ahead

Awards

High Technology Expertise Certificate
Specialized and New SMEs in Shanghai
Pudong New Area Corporate R&D Institutions
Shanghai Brand Cultivation Demonstration Enterprise
Shanghai Patent Work Pilot Enterprise
Second Prize of Shanghai Pudong Science and Technology Award
Intellectual Property Management System Certification Certificate
Third Prize of Shanghai Pudong Science and Technology Award
Shanghai Harmonious Labor Relations Standard Enterprise
Shanghai High-tech Achievement Transformation Project
Shanghai High-tech Achievement Transformation Project
Shanghai High-tech Achievement Transformation Project
Advanced Group of "Innovative Talent Competition" in Zhangjiang Hi-Tech Park

Major Scientific Research Projects

  • 2019
    Apr.
    In April, the "Tacarbitol" project obtained the Shanghai High-tech Achievement Transformation Project Certificate.
    Dec.
    In December, the "Trabectedin (raw material)" project obtained the Shanghai High-tech Achievement Transformation Project Certificate.
  • 2018
    Dec.
    In December, the "Alcalcidol Intermediate" project was approved for the "High-tech Achievement Transformation Project".
  • 2017
    Dec.
    In December, the "Highly Active Anti-tumor New Drug R&D Platform" was successfully approved for the special fund project of "Small and Micro Enterprise Entrepreneurship Innovation Base City Demonstration".
  • 2016
    Aug.
    In August, the " research and development of MMAE series of antibody-coupled drug" project was successfully approved for the 2016 Shanghai Innovation Fund.
  • 2015
    Jul.
    In July,the " research and development of a new drug for hepatitis C treatment of sofosbuvir and its tablets" was successfully approved for the Shanghai "Science and Technology Innovation Action Plan" for the cooperation project of industry-university-research-medicine in the biomedical field.
    Aug.
    In August, the " Preparation Platform of Polypeptide Drugs" Project was successfully established in 2015 Pudong Science and Technology Development Fund
    Sept.
    In September, the "industrialization of carfilzomib and its advanced intermediates and research and development of new anti-tumor drugs" projectwas successfully approved forthe Shanghai "Science and Technology Innovation Action Plan" technology innovation fund project fortechnology-based small and medium-sized enterprises.
  • 2014
    Jun.
    In June, the "Teliliptin and its key intermediates research and development" project was successfully approved for the 2014 Shanghai Innovation Fund.
  • 2013
    Jun.
    In June, the characteristic vitamin D series product "Research and Development of Paricalcitol and Its Intermediates" was successfully approved for the 2013 Shanghai Innovation Fund.
  • 2011
    Oct.
    In October, the "Innovative Research and Development of Asenapine Synthetic Process" project was successfully approved for the 2011 Shanghai Innovation Fund.
  • 2009
    Sept.
    In September, "chiral fully synthetic natural product triptolide and novel anti-tumor activity triptolide derivatives" project was successfully approved for the 2009 Shanghai Innovation Fund.
  • 2007
    May.

    In May, Chemexpress and Fudan University jointly undertook the National 863 Program "Discovery and Evaluation of New Anti-TB Lead Compounds". Chemexpress was awarded the excellent supplier of Schering-Plough's new drug customization service.

READ MORE